CARDIAC TAMPONADE AS AN ADVERSE EFFECT OF ACALABRUTINIB IN A PATIENT WITH CHRONIC LYMPHOCYTIC LEUKEMIA: CATCH THE CULPRIT

被引：0
|
作者：
Dang, Alexander [1 ]
Jancovich, Michael [1 ]
Soufi, Mohamad Khaled [1 ]
机构：
[1] Univ Texas Med Branch, Galveston, TX 77555 USA
来源：
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2021年 / 77卷 / 18期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：2177 / 2177
页数：1
相关论文
共 50 条
  • [31] Cumulative review of hypertension in patients with chronic lymphocytic leukemia treated with acalabrutinib
    Ferrajoli, Alessandra
    Follows, George
    Marmor, Yotvat
    Roos, Jack
    Bajwa, Naghmana
    Madhira, Venkata
    Nozaki, Kenji
    Miranda, Paulo
    Pennap, Dinci
    Patel, Krish
    HAEMATOLOGICA, 2025, 110 (03) : 744 - 748
  • [32] Acalabrutinib: a real breakthrough in the management of relapsed or refractory chronic lymphocytic leukemia?
    Nsiala, Laly
    Tomowiak, Cecile
    HEMATOLOGIE, 2020, 26 (03): : 146 - 147
  • [33] Acalabrutinib: a bruton tyrosine kinase inhibitor for the treatment of chronic lymphocytic leukemia
    Wolska-Washer, Anna
    Robak, Tadeusz
    EXPERT REVIEW OF HEMATOLOGY, 2022, 15 (03) : 183 - 194
  • [34] Fixed-Duration Acalabrutinib Combinations in Untreated Chronic Lymphocytic Leukemia
    Brown, Jennifer R.
    Seymour, John F.
    Jurczak, Wojciech
    Aw, Andrew
    Wach, Malgorzata
    Illes, Arpad
    Tedeschi, Alessandra
    Owen, Carolyn
    Skarbnik, Alan
    Lysak, Daniel
    Eom, Ki-Seong
    Simkovic, Martin
    Pavlovsky, Miguel Arturo
    Kater, Arnon Philip
    Eichhorst, Barbara
    Miller, Kara
    Munugalavadla, Veerendra
    Yu, Ting
    de Borja, Marianne
    Ghia, Paolo
    AMPLIFY investigators
    NEW ENGLAND JOURNAL OF MEDICINE, 2025, 392 (08): : 748 - 762
  • [35] Acalabrutinib monotherapy in patients with chronic lymphocytic leukemia who are intolerant to ibrutinib
    Awan, Farrukh T.
    Schuh, Anna
    Brown, Jennifer R.
    Furman, Richard R.
    Pagel, John M.
    Hillmen, Peter
    Stephens, Deborah M.
    Woyach, Jennifer
    Bibikova, Elena
    Charuworn, Prista
    Frigault, Melanie M.
    Hamdy, Ahmed
    Izumi, Raquel
    Linghu, Bolan
    Patel, Priti
    Wang, Min Hui
    Byrd, John C.
    BLOOD ADVANCES, 2019, 3 (09) : 1553 - 1562
  • [36] Comment on: "Cardiovascular adverse events in patients with chronic lymphocytic leukemia receiving acalabrutinib monotherapy: pooled analysis of 762 patients"
    Visentin, Andrea
    Trentin, Livio
    HAEMATOLOGICA, 2022, 107 (06) : 1489 - 1490
  • [37] Autoimmunity in chronic lymphocytic leukemia: Which B lymphocyte is the culprit?
    Lugassy, Gilles
    ISRAEL MEDICAL ASSOCIATION JOURNAL, 2006, 8 (12): : 864 - 864
  • [38] Effective treatment of pleural effusion in chronic lymphocytic leukemia with acalabrutinib: a case report
    Shuhei Kurosawa
    Takako Yokota
    Yusuke Takada
    So Okubo
    Moe Masuda
    Hitomi Nakayama
    Aki Sakurai
    Chisako Ito
    Yoshinobu Aisa
    Tomonori Nakazato
    Annals of Hematology, 2024, 103 : 1779 - 1781
  • [39] Pharmacodynamic Analysis of BTK Inhibition in Patients with Chronic Lymphocytic Leukemia Treated with Acalabrutinib
    Alsadhan, Anfal
    Cheung, Jean
    Gulrajani, Michael
    Gaglione, Erika M.
    Nierman, Pia
    Hamdy, Ahmed
    Izumi, Raquel
    Bibikova, Elena
    Patel, Priti
    Sun, Clare
    Covey, Todd
    Herman, Sarah E. M.
    Wiestner, Adrian
    CLINICAL CANCER RESEARCH, 2020, 26 (12) : 2800 - 2809
  • [40] Adverse Prognostic Features in Chronic Lymphocytic Leukemia
    Mougalian, Sarah Schellhorn
    O'Brien, Susan
    ONCOLOGY-NEW YORK, 2011, 25 (08): : 692 - 699
12345